Analysis of F8 inversions as risk factors for FVIII inhibitor development in Indian severe haemophilia A patients

被引:4
作者
Pinto, Patricia [1 ]
Ghosh, Kanjaksha [1 ]
Shetty, Shrimati [1 ]
机构
[1] ICMR, Natl Inst Immunohaematol, Mumbai 400012, Maharashtra, India
关键词
FVIII inhibitors; F8; inversions; Haemophilia A; India; FACTOR-VIII INHIBITORS; GENE;
D O I
10.1016/j.bcmd.2014.04.007
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
FVIII inhibitor development in haemophilia A (HA) patients, especially those with severe manifestations is a serious adverse effect in patients with haemophilia A, and the clinical management of these patients is very difficult as most don't respond to conventional treatment. Many genetic and non-genetic risk factors have been proposed however, these are diverse in different population groups, highlighting the importance of determining specific risk factors for each population. F8 mutations and especially inversions, which are the most common causative mutation in severe HA, have been significantly associated with inhibitor development earlier, however there is no conclusive data so far with regard to Indian haemophiliacs. This study provides novel evidence that intron 22 inversions in the F8 gene are indeed significantly associated with FVIII inhibitor development in Indian haemophiliacs. Further studies with other risk factors would enable better insights into the immune response towards FVIII in these patients, and possibly help to characterize patients at a higher risk for inhibitor development. (C) 2014 Elsevier Inc. All rights reserved.
引用
收藏
页码:161 / 163
页数:3
相关论文
共 40 条
  • [1] F8 gene dosage defects in atypical patients with severe haemophilia A
    Vencesla, A.
    Baena, M.
    Garrido, R. P.
    Nunez, R.
    Velasco, F.
    Rosell, J.
    Villar, A.
    Jimenez-Yuste, V.
    Baiget, M.
    Tizzano, E. F.
    HAEMOPHILIA, 2012, 18 (05) : 708 - 713
  • [2] Antibody profile in Indian severe haemophilia A patients with and without FVIII inhibitors
    Pinto, Patricia
    Shetty, Shrimati
    Lacroix-Desmazes, Sebastien
    Bayry, Jagadeesh
    Kaveri, Srini
    Ghosh, Kanjaksha
    IMMUNOLOGY LETTERS, 2016, 169 : 93 - 97
  • [3] Inhibitor development after switching of FVIII concentrate in multitransfused patients with severe haemophilia A
    Aznar, J. A.
    Moret, A.
    Ibanez, F.
    Vila, C.
    Cabrera, N.
    Mesa, E.
    Bonanad, S.
    HAEMOPHILIA, 2014, 20 (05) : 624 - 629
  • [4] Characterisation of two novel large F8 deletions in patients with severe haemophilia A and factor VIII inhibitors
    Roth, Lukas
    Marschalek, Rolf
    Oldenburg, Johannes
    Oyen, Florian
    Schneppenheim, Reinhard
    THROMBOSIS AND HAEMOSTASIS, 2011, 105 (02) : 279 - 284
  • [5] Prevalence of FVIII inhibitors in severe haemophilia A patients: Effect of treatment and genetic factors in an Indian population
    David, Sachin
    Nair, Sukesh C.
    Singh, G. Surender
    Abu Alex, Ansu
    Ganesan, Saravanan
    Palani, Hamenth Kumar
    Balasundaram, Nithya
    Lakshmi, Kavitha M.
    Joshi, Aditi
    Kannan, S.
    Korula, Anu
    Aboobacker, Fouzia Nambiatheyil
    Abraham, Aby
    George, Biju
    Apte, Shashikant Janardan
    Srivastava, Alok
    Mathews, Vikram
    HAEMOPHILIA, 2019, 25 (01) : 67 - 74
  • [6] F8 inversions of introns 22 and 1 confer a moderate risk of inhibitors in Mexican patients with severe hemophilia A. Concordance analysis and literature review
    Luna-Zaizar, Hilda
    Angel Gonzalez-Alcazar, Jose
    Evangelista-Castro, Natalia
    Beatriz Aguilar-Lopez, Lilia
    Luz Ruiz-Quezada, Sandra
    Patricia Beltran-Miranda, Claudia
    Rebeca Jaloma-Cruz, Ana
    BLOOD CELLS MOLECULES AND DISEASES, 2018, 71 : 45 - 52
  • [7] SCREENING FOR INVERSIONS IN THE FACTOR-VIII (F8) GENE CAUSING SEVERE HEMOPHILIA-A
    MILLAR, DS
    KAKKAR, VV
    COOPER, DN
    BLOOD COAGULATION & FIBRINOLYSIS, 1994, 5 (02) : 239 - 242
  • [8] Molecular analysis of F8 in Lebanese haemophilia A patients:: novel mutations and phenotype-genotype correlation
    Khayat, C. Djambas
    Salem, N.
    Chouery, E.
    Corbani, S.
    Moix, I.
    Nicolas, E.
    Morris, M. A.
    de Moerloose, P.
    Megarbane, A.
    HAEMOPHILIA, 2008, 14 (04) : 709 - 716
  • [9] F8 gene mutation profile in Indian hemophilia A patients: Identification of 23 novel mutations and factor VIII inhibitor risk association
    Pinto, Patricia
    Ghosh, Kanjaksha
    Shetty, Shrimati
    MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS, 2016, 786 : 27 - 33
  • [10] Treatment related factors and inhibitor development in children with severe haemophilia A
    Maclean, P. S.
    Richards, M.
    Williams, M.
    Collins, P.
    Liesner, R.
    Keeling, D. M.
    Yee, T.
    Will, A. M.
    Young, D.
    Chalmers, E. A.
    HAEMOPHILIA, 2011, 17 (02) : 282 - 287